| PERIOD ENDING | 28-Mar-09 | 29-Mar-08 | 31-Mar-07 | | Total Revenue | 17,421 | 18,331 | 18,048 | | Cost of Revenue | 9,917 | 10,583 | 10,502 | | | Gross Profit | 7,504 | 7,748 | 7,546 | | | Operating Expenses | | Research Development | 1,975 | 2,248 | 3,731 | | Selling General and Administrative | 5,939 | 5,538 | 5,456 | | Non Recurring |
-
| 153 | 361 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (410) | (191) | (2,002) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7 | (10) | 108 | | Earnings Before Interest And Taxes | (403) | (201) | (1,894) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (403) | (201) | (1,894) | | Income Tax Expense | 2 | 2 | 1 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (405) | (203) | (1,895) | | | Non-recurring Events | | Discontinued Operations | 75 | (31) | 28 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (330) | (234) | (1,867) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($330) | ($234) | ($1,867) |
|
0.22% Nasdaq 
0.06 (2.45%) 
Income Statement
